BioVaxys announces new CFO and board changes

VANCOUVER — BioVaxys Technology Corp. announces that Dasha Enenko has been appointed as its Chief Financial Officer. Dasha is a Chartered Professional Accountant with accounting experience working with private, public and non-for-profit entities in a broad range of industries, including e-commerce, technology, manufacturing, food and beverages and real estate. Her responsibilities have included preparation and filling of interim and annual financial statements for publicly traded companies, working with auditors to ensure successful completeness of audit and review engagements, and helping clients with prospectus preparations. Dasha serves as CFO of Nextgen Food Robotics Corp.

Craig Loverock, the outgoing CFO of BioVaxys, has been appointed to the Board of Directors of BioVaxys. As a financial executive, Craig will chair the audit and other relevant board committees. BioVaxys thanks Craig for his outstanding work as CFO during his tenure. Craig is filling a vacancy created by the resignation of David Wang from the Company’s Board of Directors. David is returning to reside full-time to China and will not be able to commit adequate time to serve as a director of the Company. David has been appointed as an Advisor to BioVaxys to assist the Company with business development in China, including identifying potential licensing, sales, and M&A opportunities with Chinese pharmaceutical companies.

James Passin, BioVaxys CEO, stated, “We are delighted to onboard Dasha Enenko as CFO as we continue the work of advancing our product portfolio. We thank Craig for his outstanding work as CFO during his tenure and welcome him to the Board of Directors. We are excited to continue to work with former Director David Wang on opportunities in China.”